113 related articles for article (PubMed ID: 336485)
1. [Effects of pretreatment with carteolol on metabolic changes induced by coronary artery ligation in dog left ventricular wall (author's transl)].
Saitoh Y; Ichihara K; Abiko Y
Nihon Yakurigaku Zasshi; 1977 Jul; 73(5):597-603. PubMed ID: 336485
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of endo- and epicardial glycogenolysis by propranolol in ischemic hearts.
Ichihara K; Abiko Y
Am J Physiol; 1977 Apr; 232(4):H349-53. PubMed ID: 851197
[TBL] [Abstract][Full Text] [Related]
3. Difference between endocardial and epicardial utilization of glycogen in the ischemic heart.
Ichihara K; Abiko Y
Am J Physiol; 1975 Dec; 229(6):1585-9. PubMed ID: 1082247
[TBL] [Abstract][Full Text] [Related]
4. The effect of nitroglycerin, dipyridamole, and propranolol on glycogen metabolism during coronary artery ligation in dogs.
Ichihara K; Abiko Y
Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():531-5. PubMed ID: 829648
[TBL] [Abstract][Full Text] [Related]
5. Effect of niludipine on ischemic myocardial metabolism in the dog.
Ichihara K; Ichihara M; Abiko Y
Arzneimittelforschung; 1980; 30(5):785-91. PubMed ID: 7190421
[TBL] [Abstract][Full Text] [Related]
6. Effect of carteolol, a new beta-adrenergic blocking agent, on myocardial metabolic response to coronary artery ligation in dogs.
Ichihara K; Saitoh Y; Abiko Y
Jpn J Pharmacol; 1977 Jun; 27(3):475-8. PubMed ID: 335132
[No Abstract] [Full Text] [Related]
7. A neural factor involved in increase of the glycogen phosphorylase activity after coronary ligation in both ischemic and nonischemic areas of the dog heart.
Sakai K; Abiko Y
Circ Res; 1982 Dec; 51(6):733-42. PubMed ID: 6128082
[TBL] [Abstract][Full Text] [Related]
8. Effect of verapamil and nifedipine on ischemic myocardial metabolism in dogs.
Ichihara K; Ichihara M; Abiko Y
Arzneimittelforschung; 1979; 29(10):1539-44. PubMed ID: 583218
[TBL] [Abstract][Full Text] [Related]
9. Effect of dipyridamole on the glycogen metabolism in the normal and ischemic canine myocardium.
Ichihara K; Abiko Y
Experientia; 1975 Oct; 31(10):1198-9. PubMed ID: 1204739
[No Abstract] [Full Text] [Related]
10. Inhibitory effect of trimetazidine on utilization of myocardial glycogen during coronary ligation in dogs.
Sakai K; Fukushi Y; Abiko Y
Pharmacology; 1986; 32(2):72-9. PubMed ID: 3952133
[TBL] [Abstract][Full Text] [Related]
11. Acute changes of myocardial norepinephrine and glycogen phosphorylase in ischemic and non-ischemic areas after coronary ligation in dogs.
Sakai K; Abiko Y
Jpn Circ J; 1981 Nov; 45(11):1250-5. PubMed ID: 7300006
[TBL] [Abstract][Full Text] [Related]
12. Effect of ouabain on myocardial metabolic and contractile responses to coronary ligation.
Abiko Y; Ichihara K
Eur J Pharmacol; 1978 Jan; 47(1):87-94. PubMed ID: 618733
[TBL] [Abstract][Full Text] [Related]
13. Transmural gradients of left ventricular tissue metabolites after circumflex artery ligation in dogs.
Allison TB; Ramey CA; Holsinger JW
J Mol Cell Cardiol; 1977 Oct; 9(10):837-52. PubMed ID: 915954
[No Abstract] [Full Text] [Related]
14. Characterization of the "border zone" in acute regional ischemia in the dog.
Hearse JD; Opie LH; Katzeff IE; Lubbe WF; Van der Werff TJ; Peisach M; Boulle G
Am J Cardiol; 1977 Nov; 40(5):716-26. PubMed ID: 920608
[No Abstract] [Full Text] [Related]
15. Metabolic and structural recovery of left ventricular canine myocardium from regional complete ischemia.
Isselhard W; Lauterjung KL; Witte J; Ban T; Hübner G; Giersberg O; Heugel E; Hirt HJ
Eur Surg Res; 1975; 7(3):136-55. PubMed ID: 1157819
[TBL] [Abstract][Full Text] [Related]
16. Crossover plot study of glycolytic intermediates in the ischemic canine heart.
Ichihara K; Abiko Y
Jpn Heart J; 1982 Sep; 23(5):817-28. PubMed ID: 6217359
[TBL] [Abstract][Full Text] [Related]
17. [Effects of cibenzoline on myocardial ischemia].
Ohmi H; Hino T; Yamamoto K; Kamigaki M; Nakamura K; Ichihara K; Abiko Y
Nihon Yakurigaku Zasshi; 1988 Nov; 92(5):325-35. PubMed ID: 3243514
[TBL] [Abstract][Full Text] [Related]
18. Effects of bunazosin, a selective alpha 1-adrenergic blocking agent, on myocardial energy metabolism in ischemic dog heart.
Yoshida R; Ichihara K; Abiko Y
Jpn J Pharmacol; 1990 Aug; 53(4):435-41. PubMed ID: 1976843
[TBL] [Abstract][Full Text] [Related]
19. Effect of physostigmine on ventricular fibrillation and myocardial glycogen in hypothermic dogs.
Das PK; Sinha PS
Br J Pharmacol; 1972 Mar; 44(3):391-6. PubMed ID: 5040657
[TBL] [Abstract][Full Text] [Related]
20. Effect of nipradilol on myocardial energy metabolism in the dog ischaemic heart.
Hayase N; Chiba K; Ichihara K; Inagaki S; Abiko Y
J Pharm Pharmacol; 1990 Jun; 42(6):419-22. PubMed ID: 1979622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
